Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas

Neuro Oncol. 2010 Jan;12(1):2-6. doi: 10.1093/neuonc/nop002. Epub 2009 Oct 15.

Abstract

The loss of chromosomes 1p-19q is the only prognostic molecular alteration identified in low-grade gliomas (LGGs) to date. Search for loss of heterozygosity (LOH) on chromosomes 1p, 9p, 10q, and 19q was performed in a series of 231 LGGs. Loss of chromosomes 1p-19q was strongly correlated with prolonged progression-free survival (PFS) and overall survival (OS) in univariate and multivariate analyses. LOH on 9p and 10q were associated with shortened PFS (P = .01 and .03, respectively) on univariate analysis. On multivariate analysis, LOH on 9p remained significant for PFS (P = .05), whereas LOH on 10q had a significant effect on OS (P = .02). Search for LOH 9p and 10q appears to be a useful complement to analysis of chromosomes 1p-19q in LGGs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / mortality
  • Chromosomes, Human, Pair 10 / genetics*
  • Chromosomes, Human, Pair 9 / genetics*
  • Disease-Free Survival
  • Female
  • Glioma / genetics*
  • Glioma / mortality
  • Humans
  • Kaplan-Meier Estimate
  • Loss of Heterozygosity
  • Male
  • Microsatellite Repeats / genetics
  • Middle Aged
  • Prognosis
  • Young Adult